Skip to main content
TipRanks
Go Ultimate75% OFF

Bruker (BRKR) Operating Income by Segment

493 Followers

Operating Income by Segment

Bruker reported operating income by segment of -$218.60M in Q3 2026. The highest value was $131.30M in Q3 2022.

Shows profit contribution from each business unit, revealing which segments deliver healthy margins and which are weighing on earnings. Helps identify whether revenue growth is translating into sustainable profitability and where management is focusing cost control or investment efforts.

-$300.00M-$200.00M-$100.00M$0.00$100.00M$200.00MMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

BSI Life Science’s operating income effectively disappears after 2022 because management reclassified businesses in the July 2026 reorg (Biosystems/Nano/BMID/BEST), not necessarily because core profitability vanished; BioSpin and CALID show steady, seasonally stronger profitability while Nano is more volatile but recovering. A big swing in Unallocated Expenses reflects the $135M goodwill impairment and other central charges, so GAAP profits are depressed even as non‑GAAP margins improve from realized cost savings—watch deep‑tech order lead times for delayed revenue conversion and Q4 upside.

BRKR Operating Income by Segment

PeriodUnallocated ExpensesCorporate & OtherBSI BioSpinBSI CALIDBSI Life ScienceBSI NANOBESTTotal
Q3 2026Sep 30, 2026-$233.70M-$28.70M$0.00$0.00$0.00$31.70M$12.10M-$218.60M
Q2 2026Jun 30, 2026-$183.90M-$32.80M$41.70M$72.30M$0.00$29.80M$7.60M-$65.30M
Q1 2026Mar 31, 2026-$74.10M-$29.10M$28.80M$62.60M$0.00$14.40M$7.60M$10.20M
Q4 2025Dec 31, 2025-$77.20M-$31.90M$63.00M$71.80M$0.00$45.10M$5.50M$76.30M
Q3 2025Sep 30, 2025-$157.60M-$34.00M$33.30M$76.00M$0.00$23.50M$7.00M-$51.80M
Q2 2025Jun 30, 2025-$60.00M-$21.10M$23.10M$53.30M$0.00$9.40M$7.20M$11.90M
Q1 2025Mar 31, 2025-$70.00M-$26.90M$37.10M$61.50M$0.00$23.10M$7.00M$31.80M
Q4 2024Dec 31, 2024-$105.70M-$31.70M$78.60M$78.00M$0.00$44.30M$8.60M$72.10M
Q3 2024Sep 30, 2024-$61.00M-$24.70M$56.80M$58.70M$0.00$30.60M$7.70M$68.10M
Q2 2024Jun 30, 2024-$62.40M-$24.30M$46.60M$58.40M$0.00$19.20M$10.60M$48.10M
Q1 2024Mar 31, 2024-$35.80M-$23.10M$34.60M$51.10M$0.00$29.80M$8.20M$64.80M
Q4 2023Dec 31, 2023$0.00-$40.00M$72.20M$57.70M$0.00$9.40M$4.20M$103.50M
Q3 2023Sep 30, 2023$0.00-$26.00M$52.50M$50.00M$0.00$39.00M$9.00M$124.50M
Q2 2023Jun 30, 2023$0.00-$24.00M$23.80M$44.00M$0.00$31.30M$11.10M$86.20M
Q1 2023Mar 31, 2023$0.00-$19.70M$47.40M$57.60M$0.00$29.40M$8.00M$122.70M
Q4 2022Dec 31, 2022$0.00-$22.50M$0.00$0.00$102.80M$40.80M$9.90M$131.00M
Q3 2022Sep 30, 2022$0.00-$16.40M$0.00$0.00$104.20M$35.30M$8.20M$131.30M
Q2 2022Jun 30, 2022$0.00-$17.50M$0.00$0.00$70.20M$14.60M$6.60M$73.90M
Q1 2022Mar 31, 2022$0.00-$18.30M$0.00$0.00$85.90M$22.30M$6.60M$96.50M
Q4 2021Dec 31, 2021$0.00-$18.80M$0.00$0.00$122.00M$18.30M$3.90M$125.40M
Q3 2021Sep 30, 2021$0.00-$16.90M$0.00$0.00$100.90M$21.80M$7.40M$113.20M
Q2 2021Jun 30, 2021$0.00-$15.80M$0.00$0.00$73.60M$21.00M$6.80M$85.60M
Q1 2021Mar 31, 2021$0.00-$16.20M$0.00$0.00$88.90M$12.30M$4.10M$89.10M

Related KPIs